Adaptin Bio (APTN) Amortization of Deferred Charges (2024 - 2025)
Adaptin Bio recorded quarterly Amortization of Deferred Charges of $53722.0 in Q1 2025, down 50.44% quarter-over-quarter from $108389.0 in Q4 2024, and up 101.46% year-over-year from $26666.0 in Q1 2024.
Adaptin Bio's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $53722.0 for Q1 2025.
- In Q1 2025, Amortization of Deferred Charges rose 101.46% year-over-year to $53722.0; the TTM figure through Dec 2025 stood at $53722.0 (down 77.6% YoY), while the FY2025 annual figure was $53722.0, down 77.6% from the prior year.
- Amortization of Deferred Charges came in at $53722.0 for Q1 2025 at Adaptin Bio, down from $108389.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $108389.0 in Q4 2024 to a low of $22881.0 in Q2 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 53,722.00 |
| Mar 31, 2025 | 53,722.00 |
| Dec 31, 2024 | 108,389.00 |
| Dec 31, 2024 | 108,389.00 |
| Sep 30, 2024 | 81,853.00 |
| Sep 30, 2024 | 81,853.00 |
| Jun 30, 2024 | 22,881.00 |
| Jun 30, 2024 | 22,881.00 |
| Mar 31, 2024 | 26,666.00 |
| Mar 31, 2024 | 26,666.00 |